Merck CEO Robert Davis On Molnupiravir
10 Januar 2022 - 07:33PM
ValueWalk
Following is the unofficial transcript of a CNBC interview with
Merck & Co., Inc. (NYSE:MRK) President & CEO Robert Davis
on CNBC’s “TechCheck” (M-F, 11AM-12PM ET) airing today, Monday,
January 10th. Q4 2021 hedge fund letters, conferences and more
Interview With Merck CEO Robert Davis MEG TIRRELL: Now joining us
is the Merck CEO Rob […]
https://www.valuewalk.com/merck-ceo-robert-davis-on-molnupiravir/
Merck (NYSE:MRK)
Historical Stock Chart
Von Apr 2022 bis Mai 2022
Merck (NYSE:MRK)
Historical Stock Chart
Von Mai 2021 bis Mai 2022